Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 8 of 8 for “"Type I interferonopathies"”.
-
Using CRISPR-Cas9 Techniques to Model Type I Interferonopathies
Background: Type I interferonopathies comprise a heterogenous and phenotypically diverse range of diseases, characterized by an elevated level of type I interferon (IFN) exhibited in patients accompanied by high interferon stimulated gene (ISG) scores. Type I interferonopathies are difficult to …
-
Characterizing signatures of ribonucleoside monophosphate incorporation in topoisomerase I deficient Saccharomyces cerevisiae strains
… RER pathway have been implicated in promoting type I interferonopathies in humans such as Aicardi-Goutières syndrome, a degenerative neurological encephalopathy. Topoisomerase I (Top1), an enzyme traditionally recognized as relieving torsional stress as a result of genome replication or gene …
-
Characterizing signatures of ribonucleoside monophosphate incorporation in topoisomerase I deficient Saccharomyces cerevisiae strains
… RER pathway have been implicated in promoting type I interferonopathies in humans such as Aicardi-Goutières syndrome, a degenerative neurological encephalopathy. Topoisomerase I (Top1), an enzyme traditionally recognized as relieving torsional stress as a result of genome replication or gene …
-
Type I interferon signalling regulation in the context of human Mendelian autoinflammatory disease
Type I interferons (IFN-Is) are primary antiviral cytokines. Homeostasis of IFN-I signalling is under tight regulation, with too little or too much IFN-I activity resulting in significant pathology. While impaired IFN-I signalling is characterised by immunodeficiency, inappropriate upregulation of …
-
Modeling of an Interferonopathy in Human Stem Cell-derived Microglia and Astrocytes
… (such as microglia and astrocytes) and 2) the type I interferon (IFN-I) pathway. Type I interferonopathies, a subset of rare inflammatory hereditary disorders, are characterized by chronic IFN-I activation, neurodegenerative phenotypes (such as brain calcification), and glial cell-mediated …
-
Janus Kinase Inhibitors for Autoinflammatory Disease: A First Systematic Review of Effectiveness and Safety
… with JAKi were analysed. In patients with type I interferonopathies, JAKi led to a complete response in 7 patients (7/52, 13.5%), with most patients showing a partial response (35/52, 67.3%). 10 patients (10/52, 19.2%) had no response. In Adult Onset Still´s Disease 11 (11/26, 42.3%) …
-
A de novo OAS2 F524L mutation disrupts RNase L activation and causes hyperinflammation
Background Type I interferons (IFNs) are essential mediators of antiviral defense and immune regulation within the innate immune system. Activation of IFNs is triggered by pattern recognition receptors (PRRs), which detect viral or endogenous nucleic acids. This process is tightly regulated to …
-
Discovering the function of IFI44, a hallmark interferon-stimulated gene
… anti-viral effects. The anti-viral effects of type I IFNs are predominantly mediated by a class of genes called IFN-stimulated genes (ISGs). The protein products of some ISGs inhibit virus entry, replication or egress. ISGs thus play a vital role in the immune response against viral pathogens. …